Sign in
4

Changes in Ownership

Sionna Therapeutics, Inc. Filed Acc 0001451612-25-000012

Director sold 88,878 shares at an average $34.22 ($3,041,683)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Booth Bruce · Director

Table I: Non-derivative

10 lines
Date Transaction Shares Price Value Owned after D/I
2025-10-21 Sale : show line 1 in the form 10b5-1 −22,339 $32.69 $730,262 2,360,156 I
2025-10-21 Sale : show line 2 in the form 10b5-1 −4,688 $32.69 $153,251 697,297 I
2025-10-21 Sale : show line 3 in the form 10b5-1 −19,948 $33.87 $675,639 2,340,208 I
2025-10-21 Sale : show line 4 in the form 10b5-1 −4,187 $33.87 $141,814 693,110 I
2025-10-21 Sale : show line 5 in the form 10b5-1 −5,763 $34.91 $201,186 2,334,445 I
2025-10-21 Sale : show line 6 in the form 10b5-1 −1,210 $34.91 $42,241 691,900 I
2025-10-21 Sale : show line 7 in the form 10b5-1 −25,327 $35.69 $903,921 2,309,118 I
2025-10-21 Sale : show line 8 in the form 10b5-1 −5,316 $35.69 $189,728 686,584 I
2025-10-21 Sale : show line 9 in the form 10b5-1 −83 $36.42 $3,023 2,309,035 I
2025-10-21 Sale : show line 10 in the form 10b5-1 −17 $36.42 $619 686,567 I
Open-market sales · 88,878 sh · avg $34.22 · $3,041,683
Loading xslF345X05/form4-10212025_091059.xml…